- 如果您对该产品感兴趣的话，可以
- 产品名称：Anti-phospho-PDCD4 (Ser67)抗体
- 产品型号：磷酸化凋亡相关蛋白4抗体
- 产品展商：KALANG
- 产品文档：无相关文档
- 发布时间：2018-07-15
- 在线询价
简单介绍
Anti-phospho-PDCD4 (Ser67)抗体产品质量稳定，实验效果明显，货期快，价格优惠，欢迎垂询订购！我公司长期供应**组化抗体、WB抗体、**组化试剂盒和抗体试验所需全部相关试剂、荧光标记抗体、单克隆抗体、多克隆抗体、各种标记的二抗IgG/IgM/IgD/IgA等科研实验抗体。Anti-phospho-PDCD4 (Ser67)抗体用于**组化实验,WB实验,相应的标记抗体有HRP标记抗体,FITC标记,BIO等。
产品描述
Rabbit Anti-phospho-PDCD4 (Ser67)
Cat. Number:
Anti-phospho-PDCD4 (Ser67)抗体KL-12594R
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
This gene is a tumor suppressor and encodes a protein that binds to the eukaryotic translation initiation factor 4A1 and inhibits its Anti-phospho-PDCD4 (Ser67)抗体function by preventing RNA binding. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2010]
Also known as:
PDCD4 (phospho S67); p-PDCD4 (phospho S67); Death up-regulated gene protein; Dug; H731; Ma3; MGC33046; MGC33047; Neoplastic transformation inhibitor; Neoplastic transformation inhibitor protein; Nuclear antigen H731; Nuclear antigen H731 like; Nuclear antigen H731 like protein; Nuclear antigen H731-like; PDCD 4; Anti-phospho-PDCD4 (Ser67)抗体Pdcd4; PDCD4_HUMAN; Programmed cell death 4; programmed cell death 4 (neoplastic transformation inhibitor); Programmed cell death protein 4; Protein 197/15a; Protein MA-3; Tis; Topoisomerase-inhibitor suppressed protein.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Chicken, Anti-phospho-PDCD4 (Ser67)抗体Dog, Pig, Cow, Horse, Rabbit, Sheep, .
●
Immunogen: KLH conjugated synthesised phosphopeptide derived from human PDCD4 around the phosphorylation site of Ser67.
●
Predicted Molecular Weight: 51kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications. Anti-phospho-PDCD4 (Ser67)抗体
Optimal working dilutions must be determined by the end user.
